BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7357507)

  • 21. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
    Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of camptothecin on mammalian cells in culture.
    Li LH; Fraser TJ; Olin EJ; Bhuyan BK
    Cancer Res; 1972 Dec; 32(12):2643-50. PubMed ID: 4674679
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of 5-FU action by thymidine in murine and human tumors.
    Young CW; Woodcock TM; Martin DS
    Cancer Treat Rep; 1981; 65 Suppl 3():83-7. PubMed ID: 7346156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
    Laudonio N; Zupi G; Erba E; Leonetti C; D'Incalci M
    Br J Cancer; 1990 Mar; 61(3):377-81. PubMed ID: 2328201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical modulation of 5-fluorouracil with a streptococcal preparation, OK-432, against murine colon-26 carcinoma.
    Funaki M; Gouchi A; Iwagaki H; Morimoto Y; Shimamura H; Ariki N; Tanaka N
    Acta Med Okayama; 2000 Oct; 54(5):217-25. PubMed ID: 11061571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of the inhibition of DNA synthesis by deoxyadenosine in tumor cells].
    Vornovitskaia GI; Ol'shanetskaia AD; Novikova MA; Karelina LP; Morozova NS
    Biokhimiia; 1972; 37(5):940-7. PubMed ID: 4344203
    [No Abstract]   [Full Text] [Related]  

  • 27. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 28. Age cohort variation of tumor cells.
    Maruyama Y; Lee TC; Sullivan S
    Radiology; 1973 Oct; 109(1):213-6. PubMed ID: 4783123
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
    Clifton KH; Yatvin MB
    Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
    [No Abstract]   [Full Text] [Related]  

  • 30. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estrogen and-or pituitary graft on nucleic acid synthesis of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Yanai R
    J Natl Cancer Inst; 1974 Apr; 52(4):1219-22. PubMed ID: 4826589
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental study of the combined effect of 5-fluorouracil and cyclophosphane on growth of Zajdela hepatoma and nucleic acid metabolism].
    Reztsova VV; Stukov AN; Filov VA
    Biull Eksp Biol Med; 1980 Oct; 90(10):469-71. PubMed ID: 7426710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidine inhibits the incorporation of 5-fluoro-2'-deoxyuridine to DNA of mouse mammary tumour.
    Nayak R
    Biochem Biophys Res Commun; 1992 Apr; 184(1):467-70. PubMed ID: 1533124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of cyclophosphamide and estrogen therapy in DMBA-induced rat mammary cancer.
    Kiang DT; Kennedy BJ
    Cancer; 1971 Nov; 28(5):1202-10. PubMed ID: 5125667
    [No Abstract]   [Full Text] [Related]  

  • 36. The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role?
    Mandel HG
    Cancer Treat Rep; 1981; 65 Suppl 3():63-71. PubMed ID: 6179616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.
    Wolf W; Presant CA; Servis KL; el-Tahtawy A; Albright MJ; Barker PB; Ring R; Atkinson D; Ong R; King M
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):492-6. PubMed ID: 2296605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer concepts of cancer of the colon and rectum: cell kinetics, chemotherapy, and colonic cancer.
    Dis Colon Rectum; 1972; 15(2):120-7. PubMed ID: 4260331
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA synthesis in autonomous and hormone-responsive mammary tumors.
    Takizawa S; Furth JJ; Furth J
    Cancer Res; 1970 Jan; 30(1):206-10. PubMed ID: 5462402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.